Precipio Inc. Announces the Resignation of its Chief Financial Officer and Appointment of Interim CFO
21. März 2022 17:00 ET
|
Precipio, Inc.
NEW HAVEN, Conn., March 21, 2022 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), today announced that Mr. Carl Iberger, Precipio’s CFO for the past five...
Precipio Releases Year-End 2021 Preliminary Unaudited Results and Outlook for 2022
24. Februar 2022 10:00 ET
|
Precipio, Inc.
NEW HAVEN, Conn., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), today announced its unaudited and preliminary results for 2021. The Company...
New York State Approves Precipio’s HemeScreen for POL clinical use
18. November 2021 10:00 ET
|
Precipio, Inc.
NEW HAVEN, Conn., Nov. 18, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announces that its HemeScreen RUO assay has received the required approval from...
Precipio Announces Q3-2021 and year-end Shareholder Update Call
01. November 2021 17:00 ET
|
Precipio, Inc.
NEW HAVEN, Conn., Nov. 01, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q3-2021 update call on Monday, November 15th at 5:00 PM...
American Oncology Network Partners with Precipio to Bring HemeScreen® into AON’s Laboratory
26. August 2021 10:00 ET
|
Precipio, Inc.
NEW HAVEN, Conn. and FORT MYERS, Fla., Aug. 26, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), and American Oncology Network, LLC (AON), a high-growth...
Precipio Reschedules Q2-2021 Shareholder Update Call
20. August 2021 17:00 ET
|
Precipio, Inc.
NEW HAVEN, Conn., Aug. 20, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be rescheduling its Q2-2021 update call from Monday August 23rd to...
Precipio Corrects Announcement of Q2-2021 Shareholder Update Call
13. August 2021 10:48 ET
|
Precipio, Inc.
NEW HAVEN, Conn., Aug. 13, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q2-2021 update call on Monday, August 23rd at 5:00 PM ET....
Precipio Announces Q2-2021 and year-end Shareholder Update Call
12. August 2021 17:00 ET
|
Precipio, Inc.
NEW HAVEN, Conn., Aug. 12, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q2-2021 update call on Monday, August 23rd at 5:00 PM ET....
Precipio Announces Preliminary Unaudited Q2-2021 Revenues of $2.3M
28. Juli 2021 10:00 ET
|
Precipio, Inc.
NEW HAVEN, Conn., July 28, 2021 (GLOBE NEWSWIRE) -- Specialty diagnostics Company Precipio, Inc. (NASDAQ: PRPO), announces preliminary unaudited revenues for Q2-2021 demonstrating continued...
Precipio Terminates its Equity Line
15. Juni 2021 11:00 ET
|
Precipio, Inc.
NEW HAVEN, Conn., June 15, 2021 (GLOBE NEWSWIRE) -- Specialty diagnostics Company Precipio, Inc. (NASDAQ: PRPO), announces that as part of management’s review of its current financing arrangements,...